Advertisement

Psychiatric comorbidity in adults with attention-deficit/hyperactivity disorder (ADHD)

  • Esther Sobanski
Article

Abstract

Attention-deficit/hyperactivity disorder (ADHD) is a chronic, lifelong disorder with childhood-onset, which seriously impairs the affected adults in a variety of daily living functions like educational and occupational functioning, partnership and parenting.

ADHD is associated with a high percentage of comorbid psychiatric disorders in every lifespan. In adulthood between 65–89% of all patients with ADHD suffer from one or more additional psychiatric disorders, above all mood and anxiety disorders, substance use disorders and personality disorders, which complicates the clinical picture in terms of diagnostics, treatment and outcome issues. The present overview provides information of comorbid psychiatric disorders in adults with ADHD, underlying associations and clinical implications.

Key words

Adult attention-deficit/hyperactivity disorder (ADHD) comorbidity depression anxiety disorders substance use disorders personality disorders 

References

  1. 1.
    Alm B, Sobanski E (2005) Angststörungen und Komorbidität mit Aufmerksamkeitsdefizit-/Hyperaktivitätsstörung (ADHS) im Erwachsenenalter. In: Bassler M, Leydig S (eds) Psychotherapie der Angsterkrankungen. Thieme, Stuttgart New York, pp 143–154Google Scholar
  2. 2.
    Alpert JE, Maddocks A, Nierenberg AA et al. (1996) Attention deficit hyperactivity disorder in childhood among adults with major depression. Psychiatry Res 62:213–219PubMedCrossRefGoogle Scholar
  3. 3.
    Babinski LM, Hartsough CS, Lambert NM (1999) Childhood conduct problems, hyperactivity-impulsivity and inattention as predictor of adult criminal activity. J Child Adolesc Psychiatry 40:347–355Google Scholar
  4. 4.
    Barkley RA, Fischer M, Smallish L, Fletcher K (2003) Does the treatment of attention-deficit/hyperactivity disorder with stimulants contribute to drug use abuse? A 13-year prospective study. Pediatrics 111:97–107PubMedCrossRefGoogle Scholar
  5. 5.
    Biederman J, Faraone SV, Spencer T, Wilens T, Norman D, Lapey KA et al. (1993) Patterns of psychiatric comorbidity and psychosocial functioning in adults with attention deficit hyperactivity disorder. Am J Psychiatry 150:1792–1797PubMedGoogle Scholar
  6. 6.
    Biederman J, Wilens T, Mick E et al. (1995) Psychoactive substance use disorders in adults with attention deficit hyperactivity disorder (ADHD): effects of ADHD and psychiatric comorbidity. Am J Psychiatry 152:1652–1658PubMedGoogle Scholar
  7. 7.
    Biederman J et al. (1997) Is ADHD a risk factor for psychoactive substance use disorder. Findings from a four-year prospective follow-up study. J Am Acad Child Adolesc Psychiatry 36:21–29PubMedCrossRefGoogle Scholar
  8. 8.
    Biederman J, Wilens TE, Mick E et al. (1998) Does attention-deficit hyperactivity disorder impact the developmental course of drug and alcohol abuse and dependence. Biol Psychiatry 44:269–273PubMedCrossRefGoogle Scholar
  9. 9.
    Biederman J (2003) Pharmacotherapy of attention deficit hyperactivity disorder (ADHD) decreases the risk for substance abuse: findings from a longitudinal follow-up of youths with and without ADHDJ Clin Psychiatry 64 (Suppl 11):3–8Google Scholar
  10. 10.
    Brown TE, McMullen WJ (2001) Attention deficit disorders and sleep/arousal disturbance. Ann N Y Acad Sci 931:271–286PubMedCrossRefGoogle Scholar
  11. 11.
    Carroll KM, Rounsaville KJ (1993) History and significance of childhood attention deficit disorder in treatment-seeking cocaine abusers. Compr Psychiatry 34:75–83PubMedCrossRefGoogle Scholar
  12. 12.
    Clure C, Brady KT, Saladin ME et al. (1999) Attention-deficit/hyperactivity disorder: symptom pattern and drug choice. Am J Drug Alcohol Abuse 25:441–448PubMedCrossRefGoogle Scholar
  13. 13.
    Chervin RD, Dillon JE, Bassetti C, Ganoczy DA, Pituch KJ (1997) Symptoms of sleep disorder, inattention and hyperactivity. Sleep 20:1185–1192PubMedGoogle Scholar
  14. 14.
    Crabtree VM, Ivanenko A, O’Brien LM, Gozal D (2003) Periodic limb movement disorder of sleep in children. J Sleep Res 12:73–81PubMedCrossRefGoogle Scholar
  15. 15.
    Faraone S, Biederman J (1997) Do attention deficit hyperactivity disorder and major depression share familial risk factors? J Nerv Ment Dis 185:533–541PubMedCrossRefGoogle Scholar
  16. 16.
    Fones CS, Pollack MH, Susswein L, Otto M (2000) History of childhood attention-deficit/hyperactivity disorder (ADHD) features among adults with panic disorder. J Affect Disorder 58:99–106CrossRefGoogle Scholar
  17. 17.
    Fossati A, Novella L, Donati D, Donini M, Maffei C (2002) History of childhood attention deficit/hyperactivity disorder symptoms and borderline personality disorder: a controlled study. Compr Psychiatry 43:369–377PubMedCrossRefGoogle Scholar
  18. 18.
    Geller B, Zimmerman B, Williams M, Bolhoffer K, Craney JL et al. (2000) Diagnostic characteristics of 93 cases of a prepubertal and early adolescent bipolar disorder phenotype by gender, puberty and comorbid attention deficit hyperactivity disorder. J Child Adolesc Psychopharmacol 10:157–164PubMedCrossRefGoogle Scholar
  19. 19.
    Gillberg C, Gillberg IC, Rasmussen P, Kadesjö, B, Söderstöm H, Rastam M (2004) Co-existing disorders in ADHD—Implications for diagnosis and intervention. Eur Child Adolesc Psychiatry 13 (Suppl 1):80–92CrossRefGoogle Scholar
  20. 20.
    Kessler RC, Adler L, Barkley R, Biedermann J et al. (2006) The prevalence and correlates of adult ADHD in the united States: results from the National Comorbidity Survey Replication. Am J Psychiatry 163(4):716–723PubMedCrossRefGoogle Scholar
  21. 21.
    Kooij JJS, Huub AM, Middelkoop AM, VanGils K, Buitelaar JK (2001) The effect of stimulants on nocturnal activity and sleep quality in adults with ADHD: an open-label case-control study. J Clin Psychiatry 62:952–955PubMedCrossRefGoogle Scholar
  22. 22.
    Kooij JJS, Burger H, Boonstra AM, Linden PD van der, Kalma LE, Buitelaar JK (2004) Efficacy and safety of methylphenidate in 45 adults with attention-deficit/hyperactivity disorder. A randomized placebo-controlled trial. Psychol Medicine 34:973–982CrossRefGoogle Scholar
  23. 23.
    Manchini C, Ameringen M van, Oakman JM, Figueredo D (1999) Childhood attention-deficit/hyperactivity disorder in adults with anxiety disorders. Psychol Medicine 29:515–525CrossRefGoogle Scholar
  24. 24.
    Manuzza S, Klein RG, Bessler A, Malloy P, La Padula M (1993) Adult outcome of hyperactive boys. Educational achievement, occupational rank, and psychiatric status. Arch Gen Psychiatry 50:565–567Google Scholar
  25. 25.
    Marks, Biederman J (2004) Impact of comorbidity in adults with attention-deficit/hyperactivity disorder. J Clin Psychiatry 65 (Suppl 3):3–7Google Scholar
  26. 26.
    Murphy KR, Barkley RA, Bush T (2002) Young adults with attention-deficit hyperactivity disorder: subtype differences in comorbidity, education and clinical history. J Nerv Ment Dis 190:147–157PubMedCrossRefGoogle Scholar
  27. 27.
    Nierenberg AA, Miyahara S, Spencer T, Wisniewski SR, Otto MW et al1. (2005) Clinical and diagnostic implications of lifetime comorbidity of attention-deficit/hyperactivity disorder in adults with bipolar disorder. Data from the first 1000 STEP-BD participants. Biol Psychiatry 57:1467–1473PubMedCrossRefGoogle Scholar
  28. 28.
    Philipsen A, Feige B, Hesslinger B, Ebert D, Carl C et al. (2005) Sleep in adults with attention deficit hyperactivity disorder: a controlled polysomnographic study including spectral analysis of the sleep EEG. Sleep 28:738–745Google Scholar
  29. 29.
    Rasmussen P, Gillberg C (2000) Natural outcome of ADHD with developmental coordination disorder at age 22 years: A controlled, longitudinal, community-based study. J Am Acad Child Adolesc Psychiatry 39:1424–1431PubMedCrossRefGoogle Scholar
  30. 30.
    Rösler M, Retz W, Retz-Junginger P, Hensch G, Schneider M, Supprian T (2004) Eur Arch Psychiatry Clin Neurosc 254:365–371CrossRefGoogle Scholar
  31. 31.
    Sachs GS, Thase M (2000) Comorbidity of attention deficit hyperactivity disorder with early- and late-onset bipolar disorder. Am J Psychiatry 157:466–468PubMedCrossRefGoogle Scholar
  32. 32.
    Satterfield JH, Schell A (1997) A prospective study of hyperactive boys with conduct disorder and normal boys: Adolescent and adult criminality. J Am Acad Child Adolesc Psychiatry 36:1726–1735PubMedCrossRefGoogle Scholar
  33. 33.
    Shekim WO, Asarnow RF, Hess E, Zaucha K, Wheeler N (1990) A clinical and demographic profile of a sample of adults with attention-deficit hyperactivity disorder, residual state. Compr Psychiatry 31:416–425PubMedCrossRefGoogle Scholar
  34. 34.
    Schubiner H, Tzelepis A, Millberger S et al. (2000) Prevalence of attention-deficit/hyperactivity disorder among substance use disorders. J Clin Psychiatry 61:244–251PubMedGoogle Scholar
  35. 35.
    Schweickert LA, Strober M, Moslowitz A (1997) Efficacy of methylphenidate in bulimia nervosa with comorbid attentiondeficit/hyperactivity disorder. Int J Eat Disord 21:299–301PubMedCrossRefGoogle Scholar
  36. 36.
    Secnik K, Swenson A, Lange MJ (2005) Comorbidities and costs of adults with attention-deficit hyperactivity disorder. Pharmacoeconomics 23 (1):93–102PubMedCrossRefGoogle Scholar
  37. 37.
    Sobanski E, Alm B (2004) Aufmerksamkeitsdefizit-/Hyperaktivitätsstörung (ADHS) bei Erwachsenen: Ein Überblick. Nervenarzt 75:697–715PubMedCrossRefGoogle Scholar
  38. 38.
    Sobanski E, Alm B, Krumm B (2006) Methylphenidatbehandlung bei erwachsenen Patienten mit Aufmerksamkeitsdefizit-/Hyperaktivitätsstörung (ADHS): Bedeutung von Störungssubtyp und psychiatrischer Komorbidität. Nervenarzt Mar 17 (E pub ahead of print)Google Scholar
  39. 39.
    Spencer T, Biederman J, Wilens T, Doyle R, Surman C, Prince J et al. (2005) A large double-blind, randomized trial of methylphenidate in the treatment of adults with attention-deficit/hyperactivity disorder. Biol Psychiatry 57:456–463PubMedCrossRefGoogle Scholar
  40. 40.
    Thapar A, Harrington R, McGuffin P (2001) Examining the comorbidity of ADHD-related behaviours and conduct problems using a twin-study design. Brit J Psychiatry 179:224–229CrossRefGoogle Scholar
  41. 41.
    Vermeiren R, de Clippele A, Deboutte D (2000) A descriptive survey of Flemish delinquent adolescents. J Adolesc 23:277–284PubMedCrossRefGoogle Scholar
  42. 42.
    Wagner ML, Walters AS, Fisher BC (2004) Symptoms of attention-defict/hyperactivity disorder in adults with restless legs syndrome. Sleep 27 (8):1499–1504PubMedGoogle Scholar
  43. 43.
    Wender PH, Reimherr FW, Wood D, Ward M (1985) A controlled study of methylphenidate in the treatment of attention deficit disorder, residual type, in adults. Am J Psychiatry 142:547–552PubMedGoogle Scholar
  44. 44.
    Weiss G, Hechtman L, Milroy T et al. (1985) Psychiatric status of hyperactives as adults: A controlled prospective 15-year follow-up of 63 hyperactive children. J Am Acad Child Adolesc Psychiatry 24:211–223Google Scholar
  45. 45.
    West S, McElroy, Strakowski S, Keck P, McConville B (1995) Attention-deficit hyperactivity disorder in adolesecent mania. J Affect Disord 51:145–151Google Scholar
  46. 46.
    Wilens TE, Biederman J, Prince J et al. (1996) Six-week, double-blind, placebo-controlled study of desipramine for adults with attention deficit hyperactivity disorder. Am J Psychiatry 153:1147–1153PubMedGoogle Scholar
  47. 47.
    Wilens TE et al. (1997) Attention deficit hyperactivity disorder (ADHD) is associated with early-onset substance use disorders. J Nerv Ment Dis 185:475–482PubMedCrossRefGoogle Scholar
  48. 48.
    Wilens TE (2004) Impact of ADHD and its treatment on substance use disorders. J Clin Psychiatry 65:38–45PubMedCrossRefGoogle Scholar
  49. 49.
    Wodarz N, Laufkötter R, Lange K, Johann N (2004) Aufmerksamkeitsdefizit-/Hyperaktivitätsstörung (ADHS) bei erwachsenen Alkoholabhängigen. Nervenheilkunde 9:527–533Google Scholar

Copyright information

© Steinkopff-Verlag 2006

Authors and Affiliations

  1. 1.Department of Psychiatry and PsychotherapyCentral Institute of Mental Health, J 5MannheimGermany

Personalised recommendations